Clinical trial

Salsalate Therapy to Reduce Insulin Resistance and Cardiovascular Risk

NCT00330733

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2007-01-01

PhasePHASE2 / PHASE3

Study timeline

Study start (unknown)2007-01-01Date precision: month

Registry last updated2020-01-21

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Atherosclerosisunresolved

Cardiovascular Diseaseunresolved

Inflammationunresolved

Insulin Resistanceunresolved

Noninsulin-dependent Diabetes Mellitusunresolved

Interventions

SalsalateDRUG · verified · RxNorm: salsalate

Sponsors & collaborators

VA Office of Research and Developmentlead sponsor

Joslin Diabetes Centercollaborator

Mapped research locations

PhoenixArizona, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00330733 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.